Journal article
Comparison of mRNA Vaccine Effectiveness against COVID-19-associated Hospitalization by Vaccination Source: Immunization Information Systems, Electronic Medical Records, and Self-Report — IVY Network, February 1August 31, 2022
Vaccine, Vol.41(29), pp.4249-4256
06/29/2023
DOI: 10.1016/j.vaccine.2023.05.028
PMCID: PMC10183633
PMID: 37301704
Abstract
Accurate determination of COVID-19 vaccination status is necessary to produce reliable COVID-19 vaccine effectiveness (VE) estimates. Data comparing differences in COVID-19 VE by vaccination sources (i.e., immunization information systems [IIS], electronic medical records [EMR], and self-report) are limited. We compared the number of mRNA COVID-19 vaccine doses identified by each of these sources to assess agreement as well as differences in VE estimates using vaccination data from each individual source and vaccination data adjudicated from all sources combined.
Adults aged ≥18 years who were hospitalized with COVID-like illness at 21 hospitals in 18 U.S. states participating in the IVY Network during February 1*August 31, 2022, were enrolled. Numbers of COVID-19 vaccine doses identified by IIS, EMR, and self-report were compared in kappa agreement analyses. Effectiveness of mRNA COVID-19 vaccines against COVID-19-associated hospitalization was estimated using multivariable logistic regression models to compare the odds of COVID-19 vaccination between SARS-CoV-2-positive case-patients and SARS-CoV-2-negative control-patients. VE was estimated using each source of vaccination data separately and all sources combined.
A total of 4,499 patients were included. Patients with ≥1 mRNA COVID-19 vaccine dose were identified most frequently by self-report (n=3,570, 79%), followed by IIS (n=3,272, 73%) and EMR (n=3,057, 68%). Agreement was highest between IIS and self-report for 4 doses with a kappa of 0.77 (95% CI = 0.73*0.81). VE point estimates of 3 doses against COVID-19 hospitalization were substantially lower when using vaccination data from EMR only (VE = 31%, 95% CI = 16%*43%) than when using all sources combined (VE = 53%, 95% CI = 41%*62%).
Vaccination data from EMR only may substantially underestimate COVID-19 VE.
Details
- Title: Subtitle
- Comparison of mRNA Vaccine Effectiveness against COVID-19-associated Hospitalization by Vaccination Source: Immunization Information Systems, Electronic Medical Records, and Self-Report — IVY Network, February 1August 31, 2022
- Creators
- Diya Surie - National Center for Immunization and Respiratory DiseasesLevi Bonnell - National Center for Immunization and Respiratory DiseasesJennifer DeCuir - National Center for Immunization and Respiratory DiseasesManjusha Gaglani - Baylor Scott & White HealthTresa McNeal - Baylor Scott & White HealthShekhar Ghamande - Baylor Scott & White HealthJay S. Steingrub - Baystate Medical CenterNathan I. Shapiro - Beth Israel Deaconess Medical CenterLaurence W. Busse - Emory UniversityMatthew E. Prekker - Hennepin County Medical CenterIthan D. Peltan - University of UtahSamuel M. Brown - University of UtahDavid N. Hager - Johns Hopkins MedicineHarith Ali - Johns Hopkins MedicineMichelle N. Gong - Albert Einstein College of MedicineAmira Mohamed - Montefiore Health SystemAkram Khan - Oregon Health & Science UniversityJennifer G. Wilson - Stanford UniversityNida Qadir - University of California, Los AngelesSteven Y. Chang - University of California, Los AngelesAdit A. Ginde - Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, United StatesDavid Huynh - Johns Hopkins MedicineNicholas M. Mohr - University of IowaChristopher Mallow - University of MiamiEmily T. Martin - University of MichiganAdam S. Lauring - University of MichiganNicholas J. Johnson - University of WashingtonJonathan D. Casey - Vanderbilt University Medical CenterKevin W. Gibbs - Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United StatesJennie H. Kwon - Department of Medicine, Washington University, St. Louis, MO, United StatesAdrienne Baughman - Vanderbilt University Medical CenterJames D. Chappell - Vanderbilt University Medical CenterKimberly W. Hart - Vanderbilt University Medical CenterCarlos G. Grijalva - Vanderbilt University Medical CenterJillian P. Rhoads - Vanderbilt University Medical CenterSydney A. Swan - Vanderbilt University Medical CenterH. Keipp Talbot - Vanderbilt University Medical CenterKelsey N. Womack - Vanderbilt University Medical CenterYuwei Zhu - Vanderbilt University Medical CenterMark W. Tenforde - National Center for Immunization and Respiratory DiseasesKatherine Adams - National Center for Immunization and Respiratory DiseasesWesley H. Self - Vanderbilt University Medical CenterMeredith L. McMorrow - National Center for Immunization and Respiratory Diseases
- Resource Type
- Journal article
- Publication Details
- Vaccine, Vol.41(29), pp.4249-4256
- DOI
- 10.1016/j.vaccine.2023.05.028
- PMID
- 37301704
- PMCID
- PMC10183633
- NLM abbreviation
- Vaccine
- ISSN
- 0264-410X
- eISSN
- 1873-2518
- Publisher
- Elsevier Ltd
- Grant note
- DOI: 10.13039/100000030, name: Centers for Disease Control and Prevention
- Language
- English
- Electronic publication date
- 05/15/2023
- Date published
- 06/29/2023
- Academic Unit
- Epidemiology; Emergency Medicine; Anesthesia; Injury Prevention Research Center
- Record Identifier
- 9984413081702771
Metrics
15 Record Views